Zusammenfassung
Die maligne intestinale Obstruktion (MIO) ist eine häufige Komplikation bei Patienten
mit maligner Grunderkrankung und stellt eine der größten interdisziplinären diagnostischen
und therapeutischen Herausforderungen in der Palliativmedizin dar. Die Gastroenterologie
spielt hierbei eine zentrale Rolle. Nach der diagnostischen Einordnung ist es wichtig,
mit dem Patienten und den Angehörigen adäquate Therapieziele festzulegen, die in der
Regel symptomorientiert sind. Therapeutisch stehen grundsätzlich chirurgische, endoskopische
oder konservativ-medikamentöse Maßnahmen zur Verfügung. Diese sollen anhand von Fallbeispielen
vorgestellt werden. Die MIO wird in der internationalen Literatur zunehmend als eigenständige
Entität behandelt. Anliegen dieses Beitrags ist es, die MIO in der deutschsprachigen
Literatur als solche zu vermitteln.
Abstract
Malignant bowel obstruction (MBO) is a frequent complication in patients with a progressive
malignant disorder and represents a major interdisciplinary challenge in palliative
care. Gastroenterology plays a pivotal role in the management of MBO. After appropriate
diagnostic work-up, it is important to define treatment goals with the patient and
his/her relatives, which should focus on symptom relief. Therapeutically, surgical,
endoscopic and medical options are available. These will be introduced based on case
reports. In the international literature MBO is being more and more considered as
a distinct entity. The aim of the present review is to communicate MBO as such in
the German medical literature.
Schlüsselwörter
kolorektales Karzinom - Malassimilation - Magenkarzinom - Ösophaguskarzinom - Palliativmedizin
- maligne intestinale Obstruktion
Key words
colorectal cancer - malassimilation - stomach cancer - oesophageal carcinoma - palliative
medicine - malignant bowel obstruction
Literatur
- 1
Holtmann M H, Domagk D, Weber M. et al .
Gastroenterological palliative care.
Z Gastroenterol.
2007;
46 (7)
712-724
- 2
Krouse R S.
Surgical management of malignant bowel obstruction.
Surg Oncol Clin N Am.
2004;
13 (3)
479-490
- 3
Ripamonti C, Bruera E.
Palliative management of malignant bowel obstruction.
Int J Gynecol Cancer.
2002;
12 (2)
135-143
- 4
Anthony T, Baron T, Mercadante S. et al .
Report of the clinical protocol committee: development of randomized trials for malignant
bowel obstruction.
J Pain Symptom Manage.
2007;
34 (1 Suppl)
S49-S59
- 5
Aabo K, Pedersen H, Bach F. et al .
Surgical management of intestinal obstruction in the late course of malignant disease.
Acta Chir Scand.
1984;
150 (2)
173-176
- 6
Averbach A M, Sugarbaker P H.
Recurrent intraabdominal cancer with intestinal obstruction.
Int Surg.
1995;
80 (2)
141-146
- 7 Baines M. The pathophysiology and management of malignant bowel obstruction. Doyle
D, Hanks G, MacDonald N Oxford textbook of palliative medicine Oxford; Oxford University
Press 1998: 526-534
- 8
Ripamonti C I, Easson A M, Gerdes H.
Management of malignant bowel obstruction.
Eur J Cancer.
2008;
44 (8)
1105-1115
- 9
Krebs H B, Goplerud D R.
Surgical management of bowel obstruction in advanced ovarian carcinoma.
Obstet Gynecol.
1983;
61 (3)
327-330
- 10
Kaasa S, Hjermstad M J, Loge J H.
Methodological and structural challenges in palliative care research: how have we
fared in the last decades?.
Palliat Med.
2006;
20 (8)
727-734
- 11
Easson A M, Lee K F, Brasel K. et al .
Clinical research for surgeons in palliative care: challenges and opportunities.
J Am Coll Surg.
2003;
196 (1)
141-151
- 12
Spiegel D.
Effects of psychotherapy on cancer survival.
Nat Rev Cancer.
2002;
2 (5)
383-389
- 13
Delabrousse E, Destrumelle N, Brunelle S. et al .
CT of small bowel obstruction in adults.
Abdom Imaging.
2003;
28 (2)
257-266
- 14
DiSantis D J, Ralls P W, Balfe D M. et al .
The patient with suspected small bowel obstruction: imaging strategies. American College
of Radiology. ACR Appropriateness Criteria.
Radiology.
2000;
215 (Suppl)
121-124
- 15
Furukawa A, Yamasaki M, Furuichi K. et al .
Helical CT in the diagnosis of small bowel obstruction.
Radiographics.
2001;
21 (2)
341-355
- 16
Chung C C, Meng W C, Yu S C. et al .
A prospective study on the use of water-soluble contrast follow-through radiology
in the management of small bowel obstruction.
Aust N Z J Surg.
1996;
66 (9)
598-601
- 17
Ericksen A S, Krasna M J, Mast B A. et al .
Use of gastrointestinal contrast studies in obstruction of the small and large bowel.
Dis Colon Rectum.
1990;
33 (1)
56-64
- 18
Tang E, Davis J, Silberman H.
Bowel obstruction in cancer patients.
Arch Surg.
1995;
130 (8)
832-836, discussion 836 – 837
- 19
Legendre H, Vanhuyse F, Caroli-Bosc F X. et al .
Survival and quality of life after palliative surgery for neoplastic gastrointestinal
obstruction.
Eur J Surg Oncol.
2001;
27 (4)
364-367
- 20
Makela J, Kiviniemi H, Laitinen S. et al .
Surgical management of intestinal obstruction after treatment for cancer. Case reports.
Eur J Surg.
1991;
157 (1)
73-77
- 21
Feuer D J, Broadley K E, Shepherd J H. et al .
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced
gynaecological and gastrointestinal cancer.
Cochrane Database Syst Rev.
2000;
4
CD002764
- 22
Yazdi G P, Miedema B W, Humphrey L J.
High mortality after abdominal operation in patients with large-volume malignant ascites.
J Surg Oncol.
1996;
62 (2)
93-96
- 23
Blair S L, Chu D Z, Schwarz R E.
Outcome of palliative operations for malignant bowel obstruction in patients with
peritoneal carcinomatosis from nongynecological cancer.
Ann Surg Oncol.
2001;
8 (8)
632-637
- 24
Higashi H, Shida H, Ban K. et al .
Factors affecting successful palliative surgery for malignant bowel obstruction due
to peritoneal dissemination from colorectal cancer.
Jpn J Clin Oncol.
2003;
33 (7)
357-359
- 25
Isla A M, Worthington T, Kakkar A K. et al .
A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma.
Dig Surg.
2000;
17 (2)
143-146
- 26
Choi Y B.
Laparoscopic gatrojejunostomy for palliation of gastric outlet obstruction in unresectable
gastric cancer.
Surg Endosc.
2002;
16 (11)
1620-1626
- 27
Ripamonti C, Twycross R, Baines M. et al .
Clinical-practice recommendations for the management of bowel obstruction in patients
with end-stage cancer.
Support Care Cancer.
2001;
9 (4)
223-233
- 28
Ooijen van B, Burg M E, Planting A S. et al .
Surgical treatment or gastric drainage only for intestinal obstruction in patients
with carcinoma of the ovary or peritoneal carcinomatosis of other origin.
Surg Gynecol Obstet.
1993;
176 (5)
469-474
- 29
Kozarek R A.
Endoscopic palliation of esophageal malignancy.
Endoscopy.
2003;
35 (8)
S9-S13
- 30
Domschke van der W, Foerster E C, Matek W. et al .
Self-expanding mesh stent for esophageal cancer stenosis.
Endoscopy.
1990;
22 (3)
134-136
- 31
Baron T H.
Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal
tract.
N Engl J Med.
2001;
344 (22)
1681-1687
- 32
Baron T H, Harewood G C.
Enteral self-expandable stents.
Gastrointest Endosc.
2003;
58 (3)
421-433
- 33
Lowe A S, Beckett C G, Jowett S. et al .
Self-expandable metal stent placement for the palliation of malignant gastroduodenal
obstruction: experience in a large, single, UK centre.
Clin Radiol.
2007;
62 (8)
738-744
- 34
Telford J J, Carr-Locke D L, Baron T H. et al .
Palliation of patients with malignant gastric outlet obstruction with the enteral
Wallstent: outcomes from a multicenter study.
Gastrointest Endosc.
2004;
60 (6)
916-920
- 35
Nassif T, Prat F, Meduri B. et al .
Endoscopic palliation of malignant gastric outlet obstruction using self-expandable
metallic stents: results of a multicenter study.
Endoscopy.
2003;
35 (6)
483-489
- 36
Law W L, Choi H K, Lee Y M. et al .
Palliation for advanced malignant colorectal obstruction by self-expanding metallic
stents: prospective evaluation of outcomes.
Dis Colon Rectum.
2004;
47 (1)
39-43
- 37
Camunez F, Echenagusia A, Simo G. et al .
Malignant colorectal obstruction treated by means of self-expanding metallic stents:
effectiveness before surgery and in palliation.
Radiology.
2000;
216 (2)
492-497
- 38
Sibille A, Lambert R, Souquet J C. et al .
Long-term survival after photodynamic therapy for esophageal cancer.
Gastroenterology.
1995;
108 (2)
337-344
- 39
Barr H, Kendall C, Stone N.
Photodynamic therapy for esophageal cancer: a useful and realistic option.
Technol Cancer Res Treat.
2003;
2 (1)
65-76
- 40
Knyrim K, Wagner H J, Bethge N. et al .
A controlled trial of an expansile metal stent for palliation of esophageal obstruction
due to inoperable cancer.
N Engl J Med.
1993;
329 (18)
1302-1307
- 41
Neuhaus H, Hoffmann W, Dittler H J. et al .
Implantation of self-expanding esophageal metal stents for palliation of malignant
dysphagia.
Endoscopy.
1992;
24 (5)
405-410
- 42
Adam A, Ellul J, Watkinson A F. et al .
Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser
therapy and stent placement.
Radiology.
1997;
202 (2)
344-348
- 43
Dallal H J, Smith G D, Grieve D C. et al .
A randomized trial of thermal ablative therapy versus expandable metal stents in the
palliative treatment of patients with esophageal carcinoma.
Gastrointest Endosc.
2001;
54 (5)
549-557
- 44
Siersema P D, Hop W C, Blankenstein van M. et al .
A comparison of 3 types of covered metal stents for the palliation of patients with
dysphagia caused by esophagogastric carcinoma: a prospective, randomized study.
Gastrointest Endosc.
2001;
54 (2)
145-153
- 45
Morgan R A, Ellul J P, Denton E R. et al .
Malignant esophageal fistulas and perforations: management with plastic-covered metallic
endoprostheses.
Radiology.
1997;
204 (2)
527-532
- 46
Dua K S, Kozarek R, Kim J. et al .
Self-expanding metal esophageal stent with anti-reflux mechanism.
Gastrointest Endosc.
2001;
53 (6)
603-613
- 47
Wenger U, Johnsson E, Arnelo U. et al .
An antireflux stent versus conventional stents for palliation of distal esophageal
or cardia cancer: a randomized clinical study.
Surg Endosc.
2006;
20 (11)
1675-1680
- 48
Shim C S, Jung I S, Cheon Y K. et al .
Management of malignant stricture of the esophagogastric junction with a newly designed
self-expanding metal stent with an antireflux mechanism.
Endoscopy.
2005;
37 (4)
335-339
- 49
Kinsman K J, DeGregorio B T, Katon R M. et al .
Prior radiation and chemotherapy increase the risk of life-threatening complications
after insertion of metallic stents for esophagogastric malignancy.
Gastrointest Endosc.
1996;
43 (3)
196-203
- 50
Dua K S.
Stents for palliating malignant dysphagia and fistula: is the paradigm shifting?.
Gastrointest Endosc.
2007;
65 (1)
77-81
- 51
Dormann A, Meisner S, Verin N. et al .
Self-expanding metal stents for gastroduodenal malignancies: systematic review of
their clinical effectiveness.
Endoscopy.
2004;
36 (6)
543-550
- 52
Yim H B, Jacobson B C, Saltzman J R. et al .
Clinical outcome of the use of enteral stents for palliation of patients with malignant
upper GI obstruction.
Gastrointest Endosc.
2001;
53 (3)
329-332
- 53
Feretis C, Benakis P, Dimopoulos C. et al .
Palliation of malignant gastric outlet obstruction with self-expanding metal stents.
Endoscopy.
1996;
28 (2)
225-228
- 54
Graber I, Dumas R, Filoche B. et al .
The efficacy and safety of duodenal stenting: a prospective multicenter study.
Endoscopy.
2007;
39 (9)
784-787
- 55
Seo E H, Jung M K, Park M J. et al .
Covered expandable nitinol stents for malignant gastroduodenal obstructions.
J Gastroenterol Hepatol.
2008;
23
1056-1062
- 56
Espinel J, Sanz O, Vivas S. et al .
Malignant gastrointestinal obstruction: endoscopic stenting versus surgical palliation.
Surg Endosc.
2006;
20 (7)
1083-1087
- 57
Jeurnink S M, Steyerberg E W, Hof G. et al .
Gastrojejunostomy versus stent placement in patients with malignant gastric outlet
obstruction: a comparison in 95 patients.
J Surg Oncol.
2007;
96 (5)
389-396
- 58
Wong Y T, Brams D M, Munson L. et al .
Gastric outlet obstruction secondary to pancreatic cancer: surgical vs. endoscopic
palliation.
Surg Endosc.
2002;
16 (2)
310-312
- 59
Schiefke I, Zabel-Langhennig A, Wiedmann M. et al .
Self-expandable metallic stents for malignant duodenal obstruction caused by biliary
tract cancer.
Gastrointest Endosc.
2003;
58 (2)
213-219
- 60
Mutignani M, Tringali A, Shah S G. et al .
Combined endoscopic stent insertion in malignant biliary and duodenal obstruction.
Endoscopy.
2007;
39 (5)
440-447
- 61
Maire F, Hammel P, Ponsot P. et al .
Long-term outcome of biliary and duodenal stents in palliative treatment of patients
with unresectable adenocarcinoma of the head of pancreas.
Am J Gastroenterol.
2006;
101 (4)
735-742
- 62
Mehta S, Hindmarsh A, Cheong E. et al .
Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting
for malignant gastric outflow obstruction.
Surg Endosc.
2006;
20 (2)
239-242
- 63
Rabeneck L, McCullough L B, Wray N P.
Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic
gastrostomy tube placement.
Lancet.
1997;
349 (9050)
496-498
- 64
Synofzik M.
Tube-feeding in advanced dementia. An evidence-based ethical analysis.
Nervenarzt.
2007;
78 (4)
418-428
- 65
Campagnutta E, Cannizzaro R, Gallo A. et al .
Palliative treatment of upper intestinal obstruction by gynecological malignancy:
the usefulness of percutaneous endoscopic gastrostomy.
Gynecol Oncol.
1996;
62 (1)
103-105
- 66
Pothuri B, Montemarano M, Gerardi M. et al .
Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel
obstruction due to ovarian carcinoma.
Gynecol Oncol.
2005;
96 (2)
330-334
- 67
Law W L, Choi H K, Chu K W.
Comparison of stenting with emergency surgery as palliative treatment for obstructing
primary left-sided colorectal cancer.
Br J Surg.
2003;
90 (11)
1429-1433
- 68
Fregonese D, Naspetti R, Ferrer S. et al .
Ultraflex precision colonic stent placement as a bridge to surgery in patients with
malignant colon obstruction.
Gastrointest Endosc.
2008;
67 (1)
68-73
- 69
Baron T H, Rey J F, Spinelli P.
Expandable metal stent placement for malignant colorectal obstruction.
Endoscopy.
2002;
34 (10)
823-830
- 70
Baron T H.
Acute colonic obstruction.
Gastrointest Endosc Clin N Am.
2007;
17 (2)
323-339, vi
- 71
Caceres A, Zhou Q, Iasonos A. et al .
Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic
cancer: an updated series.
Gynecol Oncol.
2008;
108 (3)
482-485
- 72
Khot U P, Lang A W, Murali K. et al .
Systematic review of the efficacy and safety of colorectal stents.
Br J Surg.
2002;
89 (9)
1096-1102
- 73
Repici A, Fregonese D, Costamagna G. et al .
Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction:
a prospective multicenter study.
Gastrointest Endosc.
2007;
66 (5)
920-927
- 74
Karoui M, Charachon A, Delbaldo C. et al .
Stents for palliation of obstructive metastatic colon cancer: impact on management
and chemotherapy administration.
Arch Surg.
2007;
142 (7)
619-623, discussion 623
- 75
Ramadori G, Lindhorst A, Armbrust T.
Colorectal tumors with complete obstruction – endoscopic recovery of passage replacing
emergency surgery? A report of two cases.
BMC Gastroenterol.
2007;
7
14
- 76
Baumhoer D, Armbrust T, Ramadori G.
Nonsurgical treatment of the primary tumor in four consecutive cases of metastasized
colorectal carcinoma.
Endoscopy.
2005;
37 (12)
1232-1236
- 77
Armbrust T, Sobotta M, Füzesi L. et al .
Chemotherapie-induced suppression to adenoma or complete suppression of the primary
in patients with stage IV colorectal cancer: report of four cases.
European Journal of Gastroenterology & Hepatology.
2007;
19 (11)
988-994
- 78
Kaasa S, De Conno F.
Palliative care research.
Eur J Cancer.
2001;
37 (Suppl 8)
S153-S159
- 79
Baines M, Oliver D J, Carter R L.
Medical management of intestinal obstruction in patients with advanced malignant disease.
A clinical and pathological study.
Lancet.
1985;
2 (8462)
990-993
- 80
Holtmann M H, Siepmann U, Mahlkow S. et al .
Gastroenterologische Symptomkontrolle in der Palliativmedizin (Teil 1).
Der Gastroenterologe.
2008;
4 (1)
64-73
- 81
Holtmann M H, Siepmann U, Mahlkow S. et al .
Gastroenterologische Symptomkontrolle in der Palliativmedizin (Teil 2).
Der Gastroenterologe.
2009;
4 (2)
147-156
- 82 Relief WHOCP. Geneva; 1996 2nd ed
- 83
Mercadante S, Porzio G, Ferrera P. et al .
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in
cancer pain management.
Eur J Pain.
2008;
12 (8)
1040-1046
- 84
Hanks G W, Conno F, Cherny N. et al .
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Br J Cancer.
2001;
84 (5)
587-593
- 85
Meissner W, Schmidt U, Hartmann M. et al .
Oral naloxone reverses opioid-associated constipation.
Pain.
2000;
84 (1)
105-109
- 86
Thomas J, Karver S, Cooney G A. et al .
Methylnaltrexone for opioid-induced constipation in advanced illness.
N Engl J Med.
2008;
358 (22)
2332-2343
- 87
Glare P, Pereira G, Kristjanson L J. et al .
Systematic review of the efficacy of antiemetics in the treatment of nausea in patients
with far-advanced cancer.
Support Care Cancer.
2004;
12 (6)
432-440
- 88
Critchley P, Plach N, Grantham M. et al .
Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative
patient: a systematic review.
J Pain Symptom Manage.
2001;
22 (2)
631-634
- 89
Feuer D J, Broadley K E.
Systematic review and meta-analysis of corticosteroids for the resolution of malignant
bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic
Review Steering Committee.
Ann Oncol.
1999;
10 (9)
1035-1041
- 90
Philip J, Lickiss N, Grant P T. et al .
Corticosteroids in the management of bowel obstruction on a gynecological oncology
unit.
Gynecol Oncol.
1999;
74 (1)
68-73
- 91
Ripamonti C, Panzeri C, Groff L. et al .
The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical
results.
Tumori.
2001;
87 (1)
1-9
- 92
Anthone G J, Bastidas J A, Orandle M S. et al .
Direct proabsorptive effect of octreotide on ionic transport in the small intestine.
Surgery.
1990;
108 (6)
1136-1141, discussion 1141 – 1142
- 93
Dean A.
The palliative effects of octreotide in cancer patients.
Chemotherapy.
2001;
47 (Suppl 2)
54-61
- 94
Bastounis E, Hadjinikolaou L, Ioannou N. et al .
Somatostatin as adjuvant therapy in the management of obstructive ileus.
Hepatogastroenterology.
1989;
36 (6)
538-539
- 95
Ripamonti C, Mercadante S, Groff L. et al .
Role of octreotide, scopolamine butylbromide, and hydration in symptom control of
patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized
trial.
J Pain Symptom Manage.
2000;
19 (1)
23-34
- 96
Mangili G, Franchi M, Mariani A. et al .
Octreotide in the management of bowel obstruction in terminal ovarian cancer.
Gynecol Oncol.
1996;
61 (3)
345-348
- 97
Mercadante S, Spoldi E, Caraceni A. et al .
Octreotide in relieving gastrointestinal symptoms due to bowel obstruction.
Palliat Med.
1993;
7 (4)
295-299
- 98
Mercadante S, Ripamonti C, Casuccio A. et al .
Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal
symptoms due to malignant inoperable bowel obstruction.
Support Care Cancer.
2000;
8 (3)
188-191
- 99
Cozzaglio L, Balzola F, Cosentino F. et al .
Outcome of cancer patients receiving home parenteral nutrition. Italian Society of
Parenteral and Enteral Nutrition (S. I. N. P.E.).
JPEN J Parenter Enteral Nutr.
1997;
21 (6)
339-342
- 100
Burge F I.
Dehydration symptoms of palliative care cancer patients.
J Pain Symptom Manage.
1993;
8 (7)
454-464
- 101
Hoda D, Jatoi A, Burnes J. et al .
Should patients with advanced, incurable cancers ever be sent home with total parenteral
nutrition? A single institution’s 20-year experience.
Cancer.
2005;
103 (4)
863-868
PD Dr. Martin H. Holtmann
Medizinische Klinik I, St. Vincenz-Krankenhaus
Rottstraße 11
45711 Datteln
Telefon: ++ 49/23 63/1 08 20 51
Fax: ++ 49/23 63/1 08 20 22
eMail: m.holtmann@vincenz-datteln.de
